FDA approves Multaq tablets (dronedarone) to treat atrial fibrillation
Posted: under Uncategorized.
Tags: Atrial Fibrillation, Cardiovascular Disease, Dronedarone, Multaq
The U.S. Food and Drug Administration has approved Multaq tablets (dronedarone) to help maintain normal heart rhythms in patients with a history of atrial fibrillation or atrial flutter (heart rhythm disorders). The drug is approved to be used in patients whose hearts have returned to normal rhythm or who will undergo drug or electric-shock treatment to restore a normal heart beat. Read the rest of this entry »
Comments (0)
Jul 02 2009









